Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Hach CM130 Chlorine Monitoring System

K-Number: K162471 · 2017-03-30

ApplicantHach Company
Decision Date2017-03-30
Product CodePSX
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Hach CM130 Chlorine Monitoring System is a medical device manufactured by Hach Company. It received FDA 510(k) clearance on 2017-03-30 under approval number K162471. The device is classified under product code PSX. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Hach CM130 Chlorine Monitoring System?

Hach CM130 Chlorine Monitoring System is a medical device that received FDA 510(k) clearance on 2017-03-30. It is manufactured by Hach Company. The 510(k) number is K162471.

When was Hach CM130 Chlorine Monitoring System approved by the FDA?

Hach CM130 Chlorine Monitoring System received FDA 510(k) clearance on 2017-03-30, under approval number K162471.

What company makes Hach CM130 Chlorine Monitoring System?

Hach CM130 Chlorine Monitoring System is manufactured by Hach Company.

What is the FDA product code for Hach CM130 Chlorine Monitoring System?

The FDA product code for Hach CM130 Chlorine Monitoring System is PSX.

Related Clinical Trials

NCT07092761 Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System RECRUITING NCT07499128 Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event ENROLLING_BY_INVITATION NCT07614581 Intra-Sessional Autonomic Arc Detection in Ketamine-Assisted Therapy for PTSD: A Signal Characterisation Pilot Study NOT_YET_RECRUITING NCT03262415 PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor COMPLETED NCT07611721 Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy. RECRUITING NCT07430293 Hybrid Closed-Loop Insulin Delivery After Pancreatectomy RECRUITING

Related PubMed Literature

PMID: 42174947 Aligning AI-Native 6G Healthcare Systems with EU Ethical and Legal Frameworks. Studies in health technology and informatics (2026) PMID: 41966529 Comparison of the AccuPower HIV-1 Quant Kit and Aptima HIV-1 Quant Dx Assay for quantification of HIV-1 plasma viral load. Diagnostic microbiology and infectious disease (2026) PMID: 41619565 Integration of materiovigilance in Unani medicine: A step towards patient safety. Journal of Ayurveda and integrative medicine (2026) PMID: 41491965 From stones to system: integrating kidney stones disease into the cardiovascular-kidney-metabolic continuum. Current opinion in nephrology and hypertension (2026)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑